PRECEDEX Side Effects

5691944-1 | Central Venous Pressure Increased, Heart Rate Increased
on Mar 20, 2008 Male patient from JAPAN , child 2. years of age, was treated with Precedex (View Usage). Patient experienced the following unwanted or unexpected effects: central venous pressure increased, heart rate increased. Precedex dosage: .

5691944-1 | Central Venous Pressure Increased, Heart Rate Increased
Patient was taking Precedex (View Usage). Patient had the following side effects: central venous pressure increased, heart rate increased on Mar 20, 2008 from JAPAN Additional patient health information: Male patient , child 2. years of age, . Precedex dosage: .

5671632-8 | Central Venous Pressure Increased, Heart Rate Increased
Adverse event was reported on Feb 27, 2008 by a Male patient taking Precedex (View Usage) (Dosage: ) . Location: JAPAN , child 2 years of age, After Precedex was administered, patient had the following side effects: central venous pressure increased, heart rate increased.

5652071-2 | Bradycardia, Loss Of Consciousness, Pallor, Sinoatrial Block, Sinus Arrest
on Feb 26, 2008 Female patient from JAPAN , child 1 years of age, weighting 21.16 lb, was diagnosed with sedation and was treated with Precedex (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, loss of consciousness, pallor, sinoatrial block, sinus arrest. Precedex dosage: 0.4 - 0.7 Mcg/kg/hr, Intravenous. During the same period patient was treated with KETALAR (View Ketalar Review and Ketalar Label ), DORMICUM (NITRAZEPAM) (View Dormicum (nitrazepam) Review and Dormicum (nitrazepam) Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), MORPHINE (View Morphine Review and Morphine Label ), PANCURONIUM BROMIDE (View Pancuronium Bromide Review and Pancuronium Bromide Label ), ULTIVA (View Ultiva Review and Ultiva Label ), MILLISROL (GLYCERYL TRINITRATE) (View Millisrol (glyceryl Trinitrate) Review and Millisrol (glyceryl Trinitrate) Label ), OPYSTAN (PETHIDINE HYDROCHLORIDE) (View Opystan (pethidine Hydrochloride) Review and Opystan (pethidine Hydrochloride) Label ).


5647928-2 | Arteriosclerosis, Cardio-respiratory Arrest, Cardiomegaly, Coronary Artery Stenosis, Foaming At Mouth, Pulmonary Embolism, Pulmonary Oedema, Ventricular Fibrillation
on Feb 14, 2008 Female patient from UNITED STATES , 76 years of age, was diagnosed with sedation and was treated with Precedex (View Usage). Patient had the following side effects: arteriosclerosis, cardio-respiratory arrest, cardiomegaly, coronary artery stenosis, foaming at mouth, pulmonary embolism (What is pulmonary embolism?), pulmonary oedema, ventricular fibrillation. Precedex dosage: 1 Ug/kg, Once, Intravenous. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), ACTIVASE (View Activase Review and Activase Label ).

5639754-5 | Brain Stem Infarction, Cardiac Arrest, Cerebrovascular Accident, Depressed Level Of Consciousness, Dysarthria
Patient was taking Precedex (View Usage). After Precedex was administered, patient had the following side effects: brain stem infarction, cardiac arrest (What is cardiac arrest?), cerebrovascular accident, depressed level of consciousness, dysarthria on Feb 12, 2008 from UNITED STATES Additional patient health information: Female patient , 39 years of age, weighting 250.0 lb, was diagnosed with sedation and. Precedex dosage: 0.4/mcg/kg/hr, Intravenous. During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PROPOFOL (View Propofol Review and Propofol Label ), SUCCINYLCHOLINE CHLORIDE (View Succinylcholine Chloride Review and Succinylcholine Chloride Label ), KETAMINE (KETAMINE) (View Ketamine (ketamine) Review and Ketamine (ketamine) Label ), ZEMURON (View Zemuron Review and Zemuron Label ), SEVOFLUORANE (SEVOFLURANE) (View Sevofluorane (sevoflurane) Review and Sevofluorane (sevoflurane) Label ), ENLON PLUS (ENLON PLUS) (View Enlon Plus (enlon-plus) Review and Enlon Plus (enlon-plus) Label ). Patient was hospitalized.

5627654-6 | Blood Pressure Decreased, Chest Pain, Dyspnoea, Feeling Abnormal, Oxygen Saturation Decreased, Therapeutic Response Unexpected, Vascular Graft Complication
Adverse event was reported on Feb 14, 2008 by a Male patient taking Precedex (View Usage) (Dosage: 100 Mgs. 4 Times Iv) was diagnosed with blood pressure management, pain (What is pain?) and. Location: UNITED STATES , 66 years of age, weighting 155.0 lb, Patient experienced the following unwanted or unexpected effects: blood pressure decreased, chest pain (What is chest pain?), dyspnoea, feeling abnormal, oxygen saturation decreased, therapeutic response unexpected, vascular graft complication.

5616732-3 | Hypotension
on Jan 22, 2008 Male patient from JAPAN , 57 years of age, weighting 152.1 lb, was diagnosed with sedation, schizophrenia, depression (What is depression?), procedural hypotension and was treated with Precedex (View Usage). Patient had the following side effects: hypotension. Precedex dosage: 0.1-0.43 Mcg/kg/hr, Not Reported, Intravenous. During the same period patient was treated with CLOCAPRAMINE HYDROCHLORIDE (CLOCAPRAMINE HYDROCHLORIDE) NOT REPORTED (50 Mg, 3 In 1 D, Oral) (View Clocapramine Hydrochloride (clocapramine Hydrochloride) Not Reported Review and Clocapramine Hydrochloride (clocapramine Hydrochloride) Not Reported Label ), LEVOMEPROMAZINE MALEATE (LEVOMEPROMAZINE MALEATE) (50 Mg, 2 In 1 D; Oral) (View Levomepromazine Maleate (levomepromazine Maleate) Review and Levomepromazine Maleate (levomepromazine Maleate) Label ), DOSULEPIN HYDROCHLORIDE ( DOSULEPIN HYDROCHLORIDE) (25 Mg, 3 In 1 D, Oral) (View Dosulepin Hydrochloride ( Dosulepin Hydrochloride) Review and Dosulepin Hydrochloride ( Dosulepin Hydrochloride) Label ), DOPAMINE HCL (1.5-8 Mcg/kg/min, Not Reported) (View Dopamine Hcl Review and Dopamine Hcl Label ), EPHEDRINE HCL 1PC SOL (Not Reported, Not Reported,) (View Ephedrine Hcl 1pc Sol Review and Ephedrine Hcl 1pc Sol Label ), NITRAZEPAM (View Nitrazepam Review and Nitrazepam Label ), FLUNITRAZEPAM (FLUNITRAZEPAM) (View Flunitrazepam (flunitrazepam) Review and Flunitrazepam (flunitrazepam) Label ).

5574128-7 | Aggression, Av Dissociation, Blood Pressure Increased, Blood Pressure Systolic Decreased, Bradycardia, Cardiac Arrest, Heart Rate Decreased, Phlebitis
on Dec 11, 2007 Male patient from JAPAN , 63 years of age, was diagnosed with sedation, delirium, insomnia, hypertension and was treated with Precedex (View Usage). After Precedex was administered, patient had the following side effects: aggression, av dissociation, blood pressure increased, blood pressure systolic decreased, bradycardia, cardiac arrest (What is cardiac arrest?), heart rate decreased, phlebitis. Precedex dosage: . During the same period patient was treated with HALOPERIDOL (Intravenous) (View Haloperidol Review and Haloperidol Label ), RILMAZAFONE HYDROCHLORIDE (RILMAZAFONE HYDROCHLORIDE) (Intravenous) (View Rilmazafone Hydrochloride (rilmazafone Hydrochloride) Review and Rilmazafone Hydrochloride (rilmazafone Hydrochloride) Label ), VALSARTAN (Intravenous) (View Valsartan Review and Valsartan Label ), DIAZEPAM (Intravenous) (View Diazepam Review and Diazepam Label ), DILTIAZEM HYDROCHLORIDE (Intravenous) (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ).

5565834-9 | Bradycardia, Cardiac Arrest
Patient was taking Precedex (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, cardiac arrest (What is cardiac arrest?) on Dec 04, 2007 from JAPAN Additional patient health information: Male patient , 63 years of age, . Precedex dosage: Intravenous.

5532194-9 | Autonomic Nervous System Imbalance, Blood Pressure Fluctuation, Heart Rate Abnormal
Adverse event was reported on Nov 14, 2007 by a Female patient taking Precedex (View Usage) (Dosage: 0.4 Mcg/kg/hr, Infusion) was diagnosed with autonomic nervous system imbalance and. Location: AUSTRALIA , 58 years of age, Patient had the following side effects: autonomic nervous system imbalance, blood pressure fluctuation, heart rate abnormal. During the same period patient was treated with ANTIBIOTICS (ANTIBIOTICS) (View Antibiotics (antibiotics) Review and Antibiotics (antibiotics) Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), GENTAMICIN SULFATE (View Gentamicin Sulfate Review and Gentamicin Sulfate Label ), TETANUS IMMUNOGLOBULIN (IMMUNOGLOBULIN HUMAN ANTI TETANUS) (View Tetanus Immunoglobulin (immunoglobulin Human Anti-tetanus) Review and Tetanus Immunoglobulin (immunoglobulin Human Anti-tetanus) Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ).

5482177-2 | Convulsion
on Sep 25, 2007 Male patient from AUSTRALIA , child 7 years of age, was treated with Precedex (View Usage). After Precedex was administered, patient had the following side effects: convulsion. Precedex dosage: Intravenous. During the same period patient was treated with POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), TOPIRAMATE (View Topiramate Review and Topiramate Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ).

5482176-0 | Convulsion, Head Injury
on Sep 25, 2007 Female patient from AUSTRALIA , child 7 years of age, was treated with Precedex (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, head injury. Precedex dosage: 0.5 Microgram, As Necessary, Intravenous. During the same period patient was treated with DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), GENTAMICIN SULFATE (View Gentamicin Sulfate Review and Gentamicin Sulfate Label ). Patient was hospitalized.

5455733-5 | Arteriosclerosis, Cardio-respiratory Arrest, Cardiomegaly, Coronary Artery Stenosis, Erythema, Foaming At Mouth, Hypoxia, Loss Of Consciousness, Procedural Complication
Patient was taking Precedex (View Usage). Patient had the following side effects: arteriosclerosis, cardio-respiratory arrest, cardiomegaly, coronary artery stenosis, erythema, foaming at mouth, hypoxia, loss of consciousness, procedural complication on Aug 30, 2007 from UNITED STATES Additional patient health information: Female patient , 76 years of age, was diagnosed with sedation and. Precedex dosage: 1 Ug/kg, Once, Intravenous. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), ACTIVASE (View Activase Review and Activase Label ).

5451908-X | Blood Albumin Decreased, Prothrombin Time Prolonged
Adverse event was reported on Sep 04, 2007 by a Male patient taking Precedex (View Usage) (Dosage: 0.4 Mcg/kg/hr, Intravenous) was diagnosed with sedation and. Location: JAPAN , 60 years of age, weighting 119.0 lb, After Precedex was administered, patient had the following side effects: blood albumin decreased, prothrombin time prolonged. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ROPIVACAINE HYDROCHLORIDE HYDRATE (ROPIVACAINE HYDROCHLORIDE) (View Ropivacaine Hydrochloride Hydrate (ropivacaine Hydrochloride) Review and Ropivacaine Hydrochloride Hydrate (ropivacaine Hydrochloride) Label ), MORPHINE (View Morphine Review and Morphine Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), CEFAZOLIN SODIUM (View Cefazolin Sodium Review and Cefazolin Sodium Label ), SIVELESTAT SODIUM HYDRATE (SIVELESTAT) (View Sivelestat Sodium Hydrate (sivelestat) Review and Sivelestat Sodium Hydrate (sivelestat) Label ).

5415332-8 | Mediastinitis
on Aug 02, 2007 Male patient from JAPAN , weighting 116.0 lb, was diagnosed with sedation and was treated with Precedex (View Usage). Patient experienced the following unwanted or unexpected effects: mediastinitis. Precedex dosage: 0.4-1.6 Mcg/kg/hr, Intravenous. During the same period patient was treated with HUMAN SERUM ALBUMIN (ALBUMIN HUMAN) (View Human Serum Albumin (albumin Human) Review and Human Serum Albumin (albumin Human) Label ), CEFOTIAM HYDROCHLORIDE (View Cefotiam Hydrochloride Review and Cefotiam Hydrochloride Label ), RANITIDINE HYDROCHLORIDE (View Ranitidine Hydrochloride Review and Ranitidine Hydrochloride Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ), NAFAMOSTAT MESILATE (NAFAMOSTAT MESILATE) (View Nafamostat Mesilate (nafamostat Mesilate) Review and Nafamostat Mesilate (nafamostat Mesilate) Label ), BROMHEXINE HYDROCHLORIDE (BROMHEXINE HYDROCHLORIDE) (View Bromhexine Hydrochloride (bromhexine Hydrochloride) Review and Bromhexine Hydrochloride (bromhexine Hydrochloride) Label ), PENTAZOCINE HYDROCHLORIDE (PENTAZOCINE HYDROCHLORIDE) (View Pentazocine Hydrochloride (pentazocine Hydrochloride) Review and Pentazocine Hydrochloride (pentazocine Hydrochloride) Label ), HYDROXYZINE HCL (View Hydroxyzine Hcl Review and Hydroxyzine Hcl Label ). Patient was hospitalized.

5409638-6 | Metabolic Acidosis
on Aug 07, 2007 Male patient from UNITED STATES , 40 years of age, weighting 149.3 lb, was diagnosed with agitation and was treated with Precedex (View Usage). Patient had the following side effects: metabolic acidosis. Precedex dosage: 0.2 Mcg/kg- 0.7 Mcg/kg Per Hour Iv Drip.

5404715-8 | Hepatic Function Abnormal, Liver Disorder, Staphylococcal Infection, Transplant Rejection
Patient was taking Precedex (View Usage). After Precedex was administered, patient had the following side effects: hepatic function abnormal, liver disorder, staphylococcal infection (What is staphylococcal infection?), transplant rejection on Jul 24, 2007 from JAPAN Additional patient health information: Female patient , 52 years of age, weighting 130.1 lb, was diagnosed with sedation and. Precedex dosage: Intravenous. During the same period patient was treated with PROGRAF (Per Oral) (View Prograf Review and Prograf Label ), DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ), SULTAMICILLIN TOSILATE (UNASYN) (View Sultamicillin Tosilate (unasyn) Review and Sultamicillin Tosilate (unasyn) Label ), SULBACTAM SODIUM CEFOPERAZONE SODIUM (View Sulbactam Sodium - Cefoperazone Sodium Review and Sulbactam Sodium - Cefoperazone Sodium Label ), ISOFLURANE (View Isoflurane Review and Isoflurane Label ).

5398789-0 | Hypotension
Adverse event was reported on Jul 12, 2007 by a Male patient taking Precedex (View Usage) (Dosage: 0.1-0.43 Mcg/kg/hr, Intravenous) was diagnosed with sedation, schizophrenia, depression (What is depression?), procedural hypotension and. Location: JAPAN , 57 years of age, weighting 152.1 lb, Patient experienced the following unwanted or unexpected effects: hypotension. During the same period patient was treated with CLOCAPRAMINE HYDROCHLORIDE (CLOCAPRAMINE HYDROCHLORIDE) (50 Mg, 3 In 1 D, Oral) (View Clocapramine Hydrochloride (clocapramine Hydrochloride) Review and Clocapramine Hydrochloride (clocapramine Hydrochloride) Label ), LEVOMEPROMAZINE MALEATE (LEVOMEPROMAZINE MALEATE) (50 Mg, 2 In 1 D, Oral) (View Levomepromazine Maleate (levomepromazine Maleate) Review and Levomepromazine Maleate (levomepromazine Maleate) Label ), DOSULEPIN HYDROCHLORIDE (DOSULEPIN HYDROCHLORIDE) (25 Mg, 3 In 1 D, Oral) (View Dosulepin Hydrochloride (dosulepin Hydrochloride) Review and Dosulepin Hydrochloride (dosulepin Hydrochloride) Label ), DOPAMINE HCL (1.5-8 Mcg/kg/min, Intravenous) (View Dopamine Hcl Review and Dopamine Hcl Label ), EPHEDRINE HCL 1PC SOL (Intravenous) (View Ephedrine Hcl 1pc Sol Review and Ephedrine Hcl 1pc Sol Label ), NITRAZEPAM (View Nitrazepam Review and Nitrazepam Label ), FLUNITRAZEPAM (FLUNITRAZEPAM) (View Flunitrazepam (flunitrazepam) Review and Flunitrazepam (flunitrazepam) Label ).

5390850-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased
on Jul 06, 2007 Male patient from JAPAN , 61 years of age, weighting 114.6 lb, was diagnosed with sedation and was treated with Precedex (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased. Precedex dosage: 0.15-0.39 Mcg/kg/hr, , Intravenous. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), BIAPENEM (OMEGACIN) (BIAPENEM) (View Biapenem (omegacin) (biapenem) Review and Biapenem (omegacin) (biapenem) Label ), INSULIN (INSULIN) (View Insulin (insulin) Review and Insulin (insulin) Label ), CIMETADINE (TAGAMET) (CIMETIDINE) (View Cimetadine (tagamet) (cimetidine) Review and Cimetadine (tagamet) (cimetidine) Label ), 10% TRANEXAMIC ACID (TRANSAMIN) (TRANEXAMIC ACID) (View 10% Tranexamic Acid (transamin) (tranexamic Acid) Review and 10% Tranexamic Acid (transamin) (tranexamic Acid) Label ), CARBAZOCHROME SODIUM SULFONATE (ADONA) (CARBAZOCHROME SODIUM SULFONATE (View Carbazochrome Sodium Sulfonate (adona) (carbazochrome Sodium Sulfonate Review and Carbazochrome Sodium Sulfonate (adona) (carbazochrome Sodium Sulfonate Label ), HUMAN SERUM ALBUMIN (ALBUMINR) (ALBUMIN HUMAN) (View Human Serum Albumin (albuminr) (albumin Human) Review and Human Serum Albumin (albuminr) (albumin Human) Label ), PANCURONIUM BROMIDE (MIOBLOCK) (PANCURONIUM BROMIDE) (View Pancuronium Bromide (mioblock) (pancuronium Bromide) Review and Pancuronium Bromide (mioblock) (pancuronium Bromide) Label ). Patient was hospitalized.

5388705-X | Mediastinitis, Post Procedural Complication
on Jul 02, 2007 Male patient from JAPAN , weighting 116.0 lb, was diagnosed with sedation and was treated with Precedex (View Usage). After Precedex was administered, patient had the following side effects: mediastinitis, post procedural complication. Precedex dosage: 0.4-1.6 Mcg/kg/hr, Intravenous. During the same period patient was treated with HUMAN SERUM ALBUMIN (ALBUMIN HUMAN) (View Human Serum Albumin (albumin Human) Review and Human Serum Albumin (albumin Human) Label ), CEFOTIAM HYDROCHLORIDE (View Cefotiam Hydrochloride Review and Cefotiam Hydrochloride Label ), RANITIDINE HYDROCHLORIDE (View Ranitidine Hydrochloride Review and Ranitidine Hydrochloride Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ), NAFAMOSTAT MESILATE (NAFAMOSTAT MESILATE) (View Nafamostat Mesilate (nafamostat Mesilate) Review and Nafamostat Mesilate (nafamostat Mesilate) Label ), BROMHEXINE HYDROCHLORIDE (BROMHEXINE HYDROCHLORIDE) (View Bromhexine Hydrochloride (bromhexine Hydrochloride) Review and Bromhexine Hydrochloride (bromhexine Hydrochloride) Label ), PENTAZOCINE HYDROCHLIRDE (PENTAZOCINE HYDROCHLORIDE) (View Pentazocine Hydrochlirde (pentazocine Hydrochloride) Review and Pentazocine Hydrochlirde (pentazocine Hydrochloride) Label ), HYDROXYZINE HCL (View Hydroxyzine Hcl Review and Hydroxyzine Hcl Label ). Patient was hospitalized.

5379440-2 | Bradycardia, Hypothermia
Patient was taking Precedex (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, hypothermia (What is hypothermia?) on Jun 25, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 6.61 lb, . Precedex dosage: See Image. During the same period patient was treated with FENTANYL CITRATE (2 Mcg/ml, Epidural Infusion) (View Fentanyl Citrate Review and Fentanyl Citrate Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), NITROUS OXIDE (NITROUS OXIDE) (View Nitrous Oxide (nitrous Oxide) Review and Nitrous Oxide (nitrous Oxide) Label ), 0.25% BUPIVACAINE (BUPIVACAINE) (View 0.25% Bupivacaine (bupivacaine) Review and 0.25% Bupivacaine (bupivacaine) Label ), 0.1% ROPIVACAINE (ROPIVACAINE) (View 0.1% Ropivacaine (ropivacaine) Review and 0.1% Ropivacaine (ropivacaine) Label ).

5321014-3 | Blood Pressure Decreased, Erythema, Heart Rate Increased
Adverse event was reported on Jan 04, 2006 by a Female patient taking Precedex (View Usage) (Dosage: See Image) was diagnosed with sedation and. Location: UNITED STATES , 71 years of age, weighting 127.9 lb, Patient had the following side effects: blood pressure decreased, erythema, heart rate increased. During the same period patient was treated with ATIVAN (View Ativan Review and Ativan Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), ANTIBIOTICS (ANTIBIOTICS) (View Antibiotics (antibiotics) Review and Antibiotics (antibiotics) Label ).

5316482-7 | Hyperbilirubinaemia
on Apr 19, 2007 Male patient from JAPAN , 57 years of age, weighting 114.6 lb, was treated with Precedex (View Usage). After Precedex was administered, patient had the following side effects: hyperbilirubinaemia. Precedex dosage: 0.4 Mcg/kg/hr, Intravenous. During the same period patient was treated with CEFTAZIDIME (MODACIN) (View Ceftazidime (modacin) Review and Ceftazidime (modacin) Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), VECURONIUM BROMIDE (MUSCURATE) (View Vecuronium Bromide (muscurate) Review and Vecuronium Bromide (muscurate) Label ), NICARDIPINE HYDROCHLORIDE (PERDIPINE) (View Nicardipine Hydrochloride (perdipine) Review and Nicardipine Hydrochloride (perdipine) Label ), ETILEFRINE HYDROCHLORIDE (EFFORTIL) (View Etilefrine Hydrochloride (effortil) Review and Etilefrine Hydrochloride (effortil) Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), MIDAZOLAM (DORMICUM) (View Midazolam (dormicum) Review and Midazolam (dormicum) Label ). Patient was hospitalized.

5299722-2 | Cardiac Index Decreased, Cardiovascular Insufficiency, Hypotension, Multi-organ Failure, Renal Failure, Respiratory Failure, Sepsis
on Apr 03, 2007 Female patient from FINLAND , 65 years of age, was diagnosed with sedation and was treated with Precedex (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac index decreased, cardiovascular insufficiency, hypotension, multi-organ failure, renal failure, respiratory failure, sepsis (What is sepsis?). Precedex dosage: See Image. During the same period patient was treated with ACTRAPID (View Actrapid Review and Actrapid Label ), DOBUJECT INFUSION (DOBUTAMINE HYDROCHLORIDE) (View Dobuject Infusion (dobutamine Hydrochloride) Review and Dobuject Infusion (dobutamine Hydrochloride) Label ), FENTANYL INFUSION (FENTANYL) (View Fentanyl Infusion (fentanyl) Review and Fentanyl Infusion (fentanyl) Label ), FURESIS (FUROSEMIDE) (FUROSEMIDE) (View Furesis (furosemide) (furosemide) Review and Furesis (furosemide) (furosemide) Label ), MERONEM (MEROPENEM) (View Meronem (meropenem) Review and Meronem (meropenem) Label ), METRONIDAZOLE BRAUN (METRONIDAZOLE) (View Metronidazole Braun (metronidazole) Review and Metronidazole Braun (metronidazole) Label ), NORADRENALINA (View Noradrenalina Review and Noradrenalina Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ).

5273296-4 | Cardiac Index Decreased, Hypotension
Patient was taking Precedex (View Usage). Patient had the following side effects: cardiac index decreased, hypotension on Mar 09, 2007 from FINLAND Additional patient health information: Female patient , 65 years of age, . Precedex dosage: See Image. During the same period patient was treated with ACTRAPID (View Actrapid Review and Actrapid Label ), DIFLUCAN INFUSION (FLUCONAZOLE) (View Diflucan Infusion (fluconazole) Review and Diflucan Infusion (fluconazole) Label ), DOBUJECT INFUSION (DOBUTAMINE HYDROCHLORIDE) (View Dobuject Infusion (dobutamine Hydrochloride) Review and Dobuject Infusion (dobutamine Hydrochloride) Label ), FENTANYL INFUSION (FENTANYL) (View Fentanyl Infusion (fentanyl) Review and Fentanyl Infusion (fentanyl) Label ), FRAGMIN INFUSION (HEPARIN FRACTION, SODIUM SALT) (View Fragmin Infusion (heparin-fraction, Sodium Salt) Review and Fragmin Infusion (heparin-fraction, Sodium Salt) Label ), FURESIS (FUROSEMIDE) (FUROSEMIDE) (View Furesis (furosemide) (furosemide) Review and Furesis (furosemide) (furosemide) Label ), MERONEM (MEROPENEM) (View Meronem (meropenem) Review and Meronem (meropenem) Label ).

5243424-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Albumin Decreased, Prothrombin Time
Adverse event was reported on Feb 02, 2007 by a Male patient taking Precedex (View Usage) (Dosage: 0.1 - 0.7 Mcg/kg/hr, Not Reported, Intravenous) was diagnosed with sedation and. Location: JAPAN , 56 years of age, weighting 97.00 lb, After Precedex was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, prothrombin time. During the same period patient was treated with SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), PROPOFOL (View Propofol Review and Propofol Label ), DROPERIDOL (View Droperidol Review and Droperidol Label ), VECURONIUM (VECURONIUM) (View Vecuronium (vecuronium) Review and Vecuronium (vecuronium) Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ALPROSTADIL (View Alprostadil Review and Alprostadil Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

5242126-9 | Brain Stem Infarction, Cardiac Arrest, Cerebrovascular Accident, Dysarthria, Sensory Disturbance
on Jan 31, 2007 Female patient from UNITED STATES , 39 years of age, weighting 250.0 lb, was diagnosed with sedation and was treated with Precedex (View Usage). Patient experienced the following unwanted or unexpected effects: brain stem infarction, cardiac arrest (What is cardiac arrest?), cerebrovascular accident, dysarthria, sensory disturbance. Precedex dosage: 0.4/mcg/kg/hr, Intravenous. During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PROPOFOL (View Propofol Review and Propofol Label ), SUCCINYLCHOLINE CHLORIDE (View Succinylcholine Chloride Review and Succinylcholine Chloride Label ), KETAMINE (KETAMINE) (View Ketamine (ketamine) Review and Ketamine (ketamine) Label ), ZEMURON (View Zemuron Review and Zemuron Label ), SEVOFLUORANE (SEVOFLURANE) (View Sevofluorane (sevoflurane) Review and Sevofluorane (sevoflurane) Label ), ENLON PLUS (ENLON PLUS) (View Enlon Plus (enlon-plus) Review and Enlon Plus (enlon-plus) Label ). Patient was hospitalized.

5228630-8 | Atelectasis
on Jan 22, 2007 Male patient from JAPAN , 22 years of age, weighting 99.21 lb, was diagnosed with postoperative care, sedation and was treated with Precedex (View Usage). Patient had the following side effects: atelectasis. Precedex dosage: Intravenous. During the same period patient was treated with NITROUS OXIDE (NITROUS OXIDE) (View Nitrous Oxide (nitrous Oxide) Review and Nitrous Oxide (nitrous Oxide) Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), OXYGEN (OXYGEN) (View Oxygen (oxygen) Review and Oxygen (oxygen) Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), BUTORPHANOL TARATRATE (View Butorphanol Taratrate Review and Butorphanol Taratrate Label ).

5216460-2 | Atelectasis, Endotracheal Intubation Complication
Patient was taking Precedex (View Usage). After Precedex was administered, patient had the following side effects: atelectasis, endotracheal intubation complication on Jan 08, 2007 from JAPAN Additional patient health information: Male patient , 22 years of age, weighting 99.21 lb, was diagnosed with sedation and. Precedex dosage: Intravenous. During the same period patient was treated with NITROUS OXIDE (NITROUS OXIDE) (View Nitrous Oxide (nitrous Oxide) Review and Nitrous Oxide (nitrous Oxide) Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), OXYGEN (OXYGEN) (View Oxygen (oxygen) Review and Oxygen (oxygen) Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), BUTORPHANOL TARATRATE (View Butorphanol Taratrate Review and Butorphanol Taratrate Label ).

5201779-1 | Atelectasis
Adverse event was reported on Dec 27, 2006 by a Male patient taking Precedex (View Usage) (Dosage: Intravenous) . Location: JAPAN , 22 years of age, weighting 99.21 lb, Patient experienced the following unwanted or unexpected effects: atelectasis. During the same period patient was treated with NITROUS OXIDE (NITROUS OXIDE) (View Nitrous Oxide (nitrous Oxide) Review and Nitrous Oxide (nitrous Oxide) Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), BUTORPHANOL TARATRATE (View Butorphanol Taratrate Review and Butorphanol Taratrate Label ), OXYGEN (OXYGEN) (View Oxygen (oxygen) Review and Oxygen (oxygen) Label ).

5195846-9 | Blood Pressure Decreased, Cardiac Disorder, Cardiac Procedure Complication, Cardiac Tamponade, Hypoxic Encephalopathy
on Dec 18, 2006 Male patient from UNITED STATES , 50 years of age, was diagnosed with sedation and was treated with Precedex (View Usage). Patient had the following side effects: blood pressure decreased, cardiac disorder, cardiac procedure complication, cardiac tamponade, hypoxic encephalopathy. Precedex dosage: 200 Mcg, Intravenous; Continuous, Intravenous.

5145702-7 | Blood Pressure Increased, Cerebral Infarction, Clonic Convulsion, Procedural Complication, Procedural Pain
on Oct 23, 2006 Male patient from JAPAN , 68 years of age, was diagnosed with sedation and was treated with Precedex (View Usage). After Precedex was administered, patient had the following side effects: blood pressure increased, cerebral infarction, clonic convulsion, procedural complication, procedural pain. Precedex dosage: Intravenous. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ).

5123363-0 | Cardiac Output Decreased, Hypertension, Post Procedural Complication
Patient was taking Precedex (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac output decreased, hypertension, post procedural complication on Sep 26, 2006 from JAPAN Additional patient health information: Female patient , 37 years of age, weighting 123.2 lb, . Precedex dosage: 0.2-0.3 Mcg/kg/hr, Not Reported, Intravenous. During the same period patient was treated with FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PANCURONIUM BROMIDE (View Pancuronium Bromide Review and Pancuronium Bromide Label ), SENEGA (SENEGA) (View Senega (senega) Review and Senega (senega) Label ), APRICOT KERNEL (View Apricot Kernel Review and Apricot Kernel Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), FERROUS CITRATE (View Ferrous Citrate Review and Ferrous Citrate Label ), SODIUM AZULENE SULFONATE (View Sodium Azulene Sulfonate Review and Sodium Azulene Sulfonate Label ).

5115373-4 | Aspartate Aminotransferase Increased, Cardiac Output Decreased, Hypoalbuminaemia
Adverse event was reported on Sep 13, 2006 by a Female patient taking Precedex (View Usage) (Dosage: 0.2 Mcg/kg/hr, Intravenous) was diagnosed with sedation and. Location: JAPAN , 40 years of age, weighting 105.8 lb, Patient had the following side effects: aspartate aminotransferase increased, cardiac output decreased, hypoalbuminaemia. During the same period patient was treated with FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), PANCURONIUM BROMIDE (View Pancuronium Bromide Review and Pancuronium Bromide Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ), CEFOTIAM HYDROCHLORIDE (View Cefotiam Hydrochloride Review and Cefotiam Hydrochloride Label ), DISOPYRAMIDE (View Disopyramide Review and Disopyramide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ).

5063383-8 | Clonic Convulsion
on Jul 14, 2006 Male patient from JAPAN , 68 years of age, was diagnosed with sedation and was treated with Precedex (View Usage). After Precedex was administered, patient had the following side effects: clonic convulsion. Precedex dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ).

5035457-9 | Cardiac Tamponade
on Jun 14, 2006 Male patient from JAPAN , 73 years of age, was treated with Precedex (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac tamponade. Precedex dosage: 0.2 - 0.7 Mcg/kg/hr, Intravenous.

5035038-7 | Cardiac Arrest, Dyspnoea, Hypotension
Patient was taking Precedex (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), dyspnoea, hypotension on Jun 22, 2006 from UNITED STATES Additional patient health information: Female patient , 76 years of age, weighting 224.0 lb, was diagnosed with induction of anaesthesia and. Precedex dosage: 25c Once Iv Bolus.

5023173-9 | Aortic Valve Stenosis, Clonic Convulsion
Adverse event was reported on May 24, 2006 by a Male patient taking Precedex (View Usage) (Dosage: ) was diagnosed with sedation and. Location: JAPAN , 68 years of age, After Precedex was administered, patient had the following side effects: aortic valve stenosis, clonic convulsion. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ).

4979595-5 | Atrioventricular Block Second Degree
on Apr 07, 2006 Male patient from JAPAN , 61 years of age, weighting 94.80 lb, was diagnosed with sedation and was treated with Precedex (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block second degree. Precedex dosage: Intravenous. During the same period patient was treated with BICARBONATED RINGER'S SOLUTION (View Bicarbonated Ringer's Solution Review and Bicarbonated Ringer's Solution Label ), BROMHEXINE (BROMHEXINE) (View Bromhexine (bromhexine) Review and Bromhexine (bromhexine) Label ), CARBAZOCHROME SODIUM SULFONATE (CARBAZOCHROME SODIUM SULFONATE) (View Carbazochrome Sodium Sulfonate (carbazochrome Sodium Sulfonate) Review and Carbazochrome Sodium Sulfonate (carbazochrome Sodium Sulfonate) Label ), AMPICILLIN SULBACTAM (UNACID) (View Ampicillin Sulbactam (unacid) Review and Ampicillin Sulbactam (unacid) Label ), PIRENZEPINE (PIRENZEPINE) (View Pirenzepine (pirenzepine) Review and Pirenzepine (pirenzepine) Label ). Patient was hospitalized.

4977399-0 | Arteriospasm Coronary, Bradycardia, Cardiac Arrest, Cardio-respiratory Arrest, Ventricular Fibrillation
on Mar 30, 2006 Male patient from JAPAN , 64 years of age, was diagnosed with sedation and was treated with Precedex (View Usage). Patient had the following side effects: arteriospasm coronary, bradycardia, cardiac arrest (What is cardiac arrest?), cardio-respiratory arrest, ventricular fibrillation. Precedex dosage: 0.25 Mg/kg/hr. During the same period patient was treated with DILTIAZEM (View Diltiazem Review and Diltiazem Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), DOPAMINE HCL (DOPAMINE HYDROCHLORIDE) (View Dopamine Hcl (dopamine Hydrochloride) Review and Dopamine Hcl (dopamine Hydrochloride) Label ), ALPROSTADIL (View Alprostadil Review and Alprostadil Label ), INSULIN HUMAN (View Insulin Human Review and Insulin Human Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ).

4973154-6 | Acute Pulmonary Oedema, Hypertension, Mitral Valve Prolapse, Tachycardia
Patient was taking Precedex (View Usage). After Precedex was administered, patient had the following side effects: acute pulmonary oedema, hypertension, mitral valve prolapse, tachycardia on Mar 28, 2006 from MEXICO Additional patient health information: Male patient , 45 years of age, was diagnosed with sedation and. Precedex dosage: Intravenous. During the same period patient was treated with MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PROPOFOL (View Propofol Review and Propofol Label ), NALBUFIN (View Nalbufin Review and Nalbufin Label ), DEXAMETAZONE (View Dexametazone Review and Dexametazone Label ), ONDASETRON (ONDANSETRON) (View Ondasetron (ondansetron) Review and Ondasetron (ondansetron) Label ).

4951661-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Liver Disorder
Adverse event was reported on Feb 28, 2006 by a Female patient taking Precedex (View Usage) (Dosage: Intravenous) was diagnosed with sedation, prophylaxis, ulcer (What is ulcer?), disseminated intravascular coagulation and. Location: JAPAN , 13 years of age, weighting 79.37 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver disorder. During the same period patient was treated with FAMOTIDINE (Intravenous) (View Famotidine Review and Famotidine Label ), GABEXATE MESILATE (GABEXATE MESILATE) (Intravenous) (View Gabexate Mesilate (gabexate Mesilate) Review and Gabexate Mesilate (gabexate Mesilate) Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ANITHROMBIN III (ANITHROMBIN III) (View Anithrombin Iii (anithrombin Iii) Review and Anithrombin Iii (anithrombin Iii) Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PROPOFOL (View Propofol Review and Propofol Label ), SIVELESTAT SODIUM HYDRATE (View Sivelestat Sodium Hydrate Review and Sivelestat Sodium Hydrate Label ).

4947738-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Liver Disorder
on Feb 28, 2006 Female patient from JAPAN , 13 years of age, weighting 79.37 lb, was diagnosed with sedation, prophylaxis, ulcer (What is ulcer?), disseminated intravascular coagulation and was treated with Precedex (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver disorder. Precedex dosage: . During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), GABEXATE MESILATE (GABEXATE MESILATE) (View Gabexate Mesilate (gabexate Mesilate) Review and Gabexate Mesilate (gabexate Mesilate) Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ANITHROMBIN III (View Anithrombin Iii Review and Anithrombin Iii Label ), MIDAZOLAM (View Midazolam Review and Midazolam Label ), PROPOFOL (View Propofol Review and Propofol Label ), SIVELESTAT SODIUM HYDRATE (View Sivelestat Sodium Hydrate Review and Sivelestat Sodium Hydrate Label ).

4939523-5 | Blood Pressure Decreased, Hepatic Function Abnormal
on Jan 23, 2006 Male patient from JAPAN , 57 years of age, weighting 147.7 lb, was diagnosed with sedation, postoperative analgesia and was treated with Precedex (View Usage). After Precedex was administered, patient had the following side effects: blood pressure decreased, hepatic function abnormal. Precedex dosage: See Image. During the same period patient was treated with ROPIVACAINE (ROPIVACAINE) (View Ropivacaine (ropivacaine) Review and Ropivacaine (ropivacaine) Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), PROPOFOL (View Propofol Review and Propofol Label ), SUXAMETHONIUM (View Suxamethonium Review and Suxamethonium Label ), PANCURONIUM (View Pancuronium Review and Pancuronium Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ).

4936764-8 | Glossoptosis, Mitral Valve Replacement, Oxygen Saturation Decreased, Renal Impairment
Patient was taking Precedex (View Usage). Patient experienced the following unwanted or unexpected effects: glossoptosis, mitral valve replacement, oxygen saturation decreased, renal impairment on Feb 06, 2006 from JAPAN Additional patient health information: Male patient , 68 years of age, weighting 149.0 lb, was diagnosed with sedation, mitral valve incompetence, postoperative analgesia and. Precedex dosage: See Image, Intravenous. During the same period patient was treated with SEVOFLURANE (Inhalation) (View Sevoflurane Review and Sevoflurane Label ), PROPOFOL (Intravenous) (View Propofol Review and Propofol Label ), MIDAZOLAM HCL (Intravenous) (View Midazolam Hcl Review and Midazolam Hcl Label ), VECURONIUM (VECURONIUM) (Intravenous) (View Vecuronium (vecuronium) Review and Vecuronium (vecuronium) Label ), FENTANYL (Intravenous) (View Fentanyl Review and Fentanyl Label ), METHYLDIGOXIN (View Methyldigoxin Review and Methyldigoxin Label ), CAPTOPRIL (View Captopril Review and Captopril Label ).

4936763-6 | Multi-organ Failure, Peritonitis, Sepsis
Adverse event was reported on Jan 30, 2006 by a Male patient taking Precedex (View Usage) (Dosage: ) . Location: JAPAN , 67 years of age, Patient had the following side effects: multi-organ failure, peritonitis, sepsis (What is sepsis?).

4932305-X | Atrioventricular Block Second Degree
on Feb 20, 2006 Male patient from JAPAN , 61 years of age, weighting 94.80 lb, was diagnosed with sedation and was treated with Precedex (View Usage). After Precedex was administered, patient had the following side effects: atrioventricular block second degree. Precedex dosage: Intravenous. During the same period patient was treated with BICARBONATED RINGER'S SOLUTION (View Bicarbonated Ringer's Solution Review and Bicarbonated Ringer's Solution Label ), BROMHEXINE (BROMHEXINE) (View Bromhexine (bromhexine) Review and Bromhexine (bromhexine) Label ), CARBAZOCHROME SODIUM SULFONATE (CARBAZOCHROME SODIUM SULFONATE) (View Carbazochrome Sodium Sulfonate (carbazochrome Sodium Sulfonate) Review and Carbazochrome Sodium Sulfonate (carbazochrome Sodium Sulfonate) Label ), AMPICILLIN SULBACTAM (UNACID) (View Ampicillin Sulbactam (unacid) Review and Ampicillin Sulbactam (unacid) Label ), PIRENZEPINE (PIRENZEPINE) (View Pirenzepine (pirenzepine) Review and Pirenzepine (pirenzepine) Label ). Patient was hospitalized.

4932209-2 | Bradycardia, Cardiac Arrest, Ventricular Fibrillation
on Feb 17, 2006 Male patient from JAPAN , 64 years of age, was diagnosed with sedation and was treated with Precedex (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, cardiac arrest (What is cardiac arrest?), ventricular fibrillation. Precedex dosage: 0.25 Mg/kg/hr. During the same period patient was treated with DILTIAZEM (View Diltiazem Review and Diltiazem Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), DOPAMINE HCL (DOPAMINE HYDROCHLORIDE) (View Dopamine Hcl (dopamine Hydrochloride) Review and Dopamine Hcl (dopamine Hydrochloride) Label ), ALPROSTADIL (View Alprostadil Review and Alprostadil Label ), INSULIN HUMAN (INSULIN HUMAN) (View Insulin Human (insulin Human) Review and Insulin Human (insulin Human) Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ).

4906824-6 | Aspartate Aminotransferase Abnormal, Blood Creatinine Abnormal, Haemodialysis, Hypoalbuminaemia, Prothrombin Time Prolonged
Patient was taking Precedex (View Usage). Patient had the following side effects: aspartate aminotransferase abnormal, blood creatinine abnormal, haemodialysis, hypoalbuminaemia, prothrombin time prolonged on Jan 13, 2006 from JAPAN Additional patient health information: Male patient , 75 years of age, weighting 176.4 lb, was diagnosed with sedation and. Precedex dosage: 0.6 - 0.7 Mcg/kg/hr, Intravenous. During the same period patient was treated with PROPOFOL (Intravenous) (View Propofol Review and Propofol Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), BENZBROMARONE (BENZBROMARONE) (View Benzbromarone (benzbromarone) Review and Benzbromarone (benzbromarone) Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), ISOSORBIDE (ISOSORBIDE) (View Isosorbide (isosorbide) Review and Isosorbide (isosorbide) Label ), BEZAFIBRATE (BEZAFIBRATE) (View Bezafibrate (bezafibrate) Review and Bezafibrate (bezafibrate) Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).